Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NXPI vs MRNA✓SelectedUSD · MRNANXPI vs MRNA performance historyLatest closeAs of-0.66%11/17
Stock and ETF performance explorer

NXPI vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+275.3%
MRNA return
+840.0%
Excess return
-564.7%
Maximum drawdown
-53.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.7%-3.9%+3.3%-0.4%
7D-3.5%-17.6%+14.1%-2.2%
30D+10.1%-5.1%+15.2%+10.3%
3M+9.0%+220.8%-211.8%-5.3%
6M-12.7%+321.7%-334.4%-27.3%
YTD+17.9%+601.3%-583.4%-8.8%
1Y+34.9%+735.2%-700.3%+1.9%
3Y+32.5%+170.5%-138.0%+9.9%
5Y+27.1%-14.6%+41.7%+11.9%
All+275.3%+840.0%-564.7%+228.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling